PMID- 15620241 OWN - NLM STAT- MEDLINE DCOM- 20050310 LR - 20181113 IS - 0163-3864 (Print) IS - 1520-6025 (Electronic) IS - 0163-3864 (Linking) VI - 67 IP - 12 DP - 2004 Dec TI - Laurenditerpenol, a new diterpene from the tropical marine alga Laurenciaintricata that potently inhibits HIF-1 mediated hypoxic signaling in breast tumor cells. PG - 2002-7 AB - The degree of tumor hypoxia correlates with advanced disease stages and treatment resistance. The transcription factor hypoxia-inducible factor-1 (HIF-1) promotes tumor cell adaptation and survival under hypoxic conditions. Therefore, specific HIF-1 inhibitors represent an important new class of potential tumor-selective therapeutic agents. A T47D human breast tumor cell-based reporter assay was used to examine extracts of plants and marine organisms for inhibitors of HIF-1 activation. Bioassay-guided fractionation of the lipid extract of the red alga Laurencia intricata yielded a structurally novel diterpene, laurenditerpenol (1). The structure of 1 was determined spectroscopically. The relative configurations of the substituents of each ring system were assigned on the basis of NOESY correlations. The absolute configuration of position C-1 was determined by the modified Mosher ester procedure (directly in NMR tubes). Compound 1 potently inhibited hypoxia-activated HIF-1 (IC50: 0.4 microM) and hypoxia-induced VEGF (a potent angiogenic factor) in T47D cells. Compound 1 selectively inhibits HIF-1 activation by hypoxia but not iron chelator-induced activation. Further, 1 suppresses tumor cell survival under hypoxic conditions without affecting normoxic cell growth. Compound 1 inhibits HIF-1 by blocking the induction of the oxygen-regulated HIF-1alpha protein. Mitochondrial respiration studies revealed that 1 suppresses oxygen consumption. FAU - Mohammed, Kaleem A AU - Mohammed KA AD - Department of Pharmacognosy, National Center for Natural Products Research, and Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, Mississippi 38677-1848, USA. FAU - Hossain, Chowdhury Faiz AU - Hossain CF FAU - Zhang, Lei AU - Zhang L FAU - Bruick, Richard K AU - Bruick RK FAU - Zhou, Yu-Dong AU - Zhou YD FAU - Nagle, Dale G AU - Nagle DG LA - eng GR - R01 CA098787/CA/NCI NIH HHS/United States GR - R01 CA098787-01A2/CA/NCI NIH HHS/United States GR - R56 CA098787/CA/NCI NIH HHS/United States GR - CA 98787-01/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Nat Prod JT - Journal of natural products JID - 7906882 RN - 0 (Antineoplastic Agents) RN - 0 (DNA-Binding Proteins) RN - 0 (Diterpenes) RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Nuclear Proteins) RN - 0 (Transcription Factors) RN - 0 (laurenditerpenol) SB - IM MH - Antineoplastic Agents/chemistry/*isolation & purification/pharmacology MH - Breast Neoplasms MH - DNA-Binding Proteins/*antagonists & inhibitors MH - Diterpenes/chemistry/*isolation & purification/pharmacology MH - Dose-Response Relationship, Drug MH - Humans MH - *Hypoxia MH - Hypoxia-Inducible Factor 1 MH - Hypoxia-Inducible Factor 1, alpha Subunit MH - Mitochondria/metabolism MH - Molecular Structure MH - Nuclear Magnetic Resonance, Biomolecular MH - Nuclear Proteins/*antagonists & inhibitors MH - Rhodophyta/*chemistry MH - Stereoisomerism MH - Transcription Factors/*antagonists & inhibitors PMC - PMC2910713 MID - NIHMS216837 EDAT- 2004/12/29 09:00 MHDA- 2005/03/11 09:00 PMCR- 2010/07/27 CRDT- 2004/12/29 09:00 PHST- 2004/12/29 09:00 [pubmed] PHST- 2005/03/11 09:00 [medline] PHST- 2004/12/29 09:00 [entrez] PHST- 2010/07/27 00:00 [pmc-release] AID - 10.1021/np049753f [doi] PST - ppublish SO - J Nat Prod. 2004 Dec;67(12):2002-7. doi: 10.1021/np049753f.